-
China continues to lead smartphone innovation
Apr 30, 2021
It is strange to think that just 20 years ago, I would have had to pay more than $10,000 to get the quality of camera as is integrated into my phone today.
-
Baidu to launch China's first driverless taxi service in Beijing
Apr 25, 2021
Baidu said on Thursday it will launch China's first robotaxi service in Beijing on May 2 and charge passengers for the driverless rides, marking a new step in efforts to run autonomous vehicles as a business in the country.
-
Tencent takes steps to ensure sustainability through AI
Apr 25, 2021
Tencent Holdings Ltd has pledged to establish a new corporate department and invest in 50 billion yuan to promote "sustainable social value innovation".
-
IPR protection effort makes great strides
Apr 25, 2021
hina has seen stronger protection of intellectual property rights and faster development of innovation under the particular care and high requirements of the central leadership, authorities and IPR experts said.
-
Huawei positioned for sustainable 5G innovation
Apr 16, 2021
Huawei Technologies Co is well-positioned to pursue sustainable innovation in 5G thanks to its long-term spending in research and development, despite challenges, a company executive said.
-
Tencent announces 50b yuan of investment in public welfare
Apr 16, 2021
Chinese tech giant Tencent announced on Monday that the company will sponsor a public welfare investment initiative worth 50 billion yuan (about $7.66 billion) to promote "sustainable social value innovation."
-
China's mobile phone shipments soar in March
Apr 16, 2021
China's mobile phone shipments soared 65.9 percent year-on-year to 36.09 million units last month, data from the China Academy of Information and Communications Technology (CAICT) shows.
-
BeiGene wins approval for commercial manufacturing of antibody
Apr 9, 2021
Chinese biotech company BeiGene Ltd announced on Thursday the approval from the China National Medical Products Administration to begin manufacturing commercial supply of its approved anti-PD-1 antibody, tislelizumab, at its biologics facility in Guangzhou, Guangdong province.